<< Back To Search

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Notify the Multiple Myeloma Research Foundation you are interested in this trial
NCT05827016
Age 18 +
Sex Both
Phase Phase 3
Third Opinion Trial Synopsis
This study wants to find out which treatment is better after a certain kind of stem cell transplant for people with newly diagnosed multiple myeloma. They want to compare how well the drug iberdomide works to the drug lenalidomide.
Third Opinion AI Generated Synopsis

Trial Summary
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).
from ClinicalTrials.gov

Locations & Contact

Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?

Contacts: